Finance

Lists
PANACEABIO:NSE
Panacea Biotec Ltd
360,00 ₹
+0,84%
(+3,00) 1D
16 հոկ, 15:30:02 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PANACEABIO...
Open
356,60 ₹
High
363,45 ₹
Low
351,00 ₹
Mkt. cap
22,05 մլրդ
Avg. vol.
85,54 հզր
Volume
25,78 հզր
52-wk high
647,00 ₹
52-wk low
292,40 ₹
EPS
-1,16 ₹
Shares outstanding
61,25 մլն
No. of employees
2 հզր
Open
356,60 ₹
High
363,45 ₹
Low
351,00 ₹
Mkt. cap
22,05 մլրդ
Avg. vol.
85,54 հզր
Volume
25,78 հզր
52-wk high
647,00 ₹
52-wk low
292,40 ₹
EPS
-1,16 ₹
Shares outstanding
61,25 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2,1 հզր
Founded1984
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,41 մլրդ
1,65 մլրդ
1,67 մլրդ
2,00 մլրդ
Cost of goods sold
589,40 մլն
679,30 մլն
763,93 մլն
1,02 մլրդ
Cost of revenue
589,40 մլն
679,30 մլն
763,93 մլն
1,02 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477,10 մլն
405,30 մլն
607,88 մլն
441,60 մլն
Operating expense
1,08 մլրդ
939,70 մլն
849,37 մլն
1,00 մլրդ
Total operating expenses
1,67 մլրդ
1,62 մլրդ
1,61 մլրդ
2,02 մլրդ
Operating income
-261,30 մլն
32,90 մլն
54,24 մլն
-22,30 մլն
Other non operating income
64,00 մլն
22,80 մլն
-149,85 մլն
42,40 մլն
EBT including unusual items
-191,70 մլն
64,90 մլն
-12,49 մլն
35,70 մլն
EBT excluding unusual items
-218,70 մլն
37,20 մլն
-47,72 մլն
8,30 մլն
Income tax expense
-51,60 մլն
26,00 մլն
-2,46 մլն
13,70 մլն
Effective tax rate
26,92%
40,06%
19,70%
38,38%
Other operating expenses
522,70 մլն
449,90 մլն
162,69 մլն
480,30 մլն
Net income
-139,20 մլն
39,80 մլն
5,13 մլն
23,00 մլն
Net profit margin
-9,86%
2,41%
0,31%
1,15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
41,64 մլն
-
Interest expense
-21,40 մլն
-18,50 մլն
-5,60 մլն
-11,80 մլն
Net interest expenses
-21,40 մլն
-18,50 մլն
36,04 մլն
-11,80 մլն
Depreciation and amortization charges
83,40 մլն
84,50 մլն
78,80 մլն
79,00 մլն
EBITDA
-177,60 մլն
113,44 մլն
129,51 մլն
60,35 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps